HEADER ISOMERASE 10-FEB-04 1SB8 TITLE CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA UDP-N-ACETYLGLUCOSAMINE 4- TITLE 2 EPIMERASE COMPLEXED WITH UDP-N-ACETYLGALACTOSAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: WBPP; COMPND 3 CHAIN: A; COMPND 4 EC: 5.1.3.7; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 287; SOURCE 4 GENE: WBPP; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET23 DERIVATIVE KEYWDS WBPP, EPIMERASE, 4-EPIMERASE, UDP-GALNAC, UDP-GLCNAC, SDR, GALE, NAD, KEYWDS 2 SYK, PSEUDOMONAS AERUGINOSA, UDP, N-ACETYLGLUCOSAMINE, N- KEYWDS 3 ACETYLGALACTOSAMINE, UDP-GLC, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.ISHIYAMA,C.CREUZENET,J.S.LAM,A.M.BERGHUIS REVDAT 4 23-AUG-23 1SB8 1 REMARK SEQADV REVDAT 3 13-JUL-11 1SB8 1 VERSN REVDAT 2 24-FEB-09 1SB8 1 VERSN REVDAT 1 25-MAY-04 1SB8 0 JRNL AUTH N.ISHIYAMA,C.CREUZENET,J.S.LAM,A.M.BERGHUIS JRNL TITL CRYSTAL STRUCTURE OF WBPP, A GENUINE UDP-N-ACETYLGLUCOSAMINE JRNL TITL 2 4-EPIMERASE FROM PSEUDOMONAS AERUGINOSA: SUBSTRATE JRNL TITL 3 SPECIFICITY IN UDP-HEXOSE 4-EPIMERASES. JRNL REF J.BIOL.CHEM. V. 279 22635 2004 JRNL REFN ISSN 0021-9258 JRNL PMID 15016816 JRNL DOI 10.1074/JBC.M401642200 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 145620.510 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 23213 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.228 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2334 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.50 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3202 REMARK 3 BIN R VALUE (WORKING SET) : 0.2040 REMARK 3 BIN FREE R VALUE : 0.2640 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 358 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.014 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2662 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 182 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 11.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.28000 REMARK 3 B22 (A**2) : -4.02000 REMARK 3 B33 (A**2) : -8.26000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21 REMARK 3 ESD FROM SIGMAA (A) : 0.13 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.210 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.830 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.830 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.39 REMARK 3 BSOL : 59.19 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NAD_NI.PAR REMARK 3 PARAMETER FILE 3 : UD2_NI.PAR REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NAD_NI.TOP REMARK 3 TOPOLOGY FILE 3 : UD2_NI.TOP REMARK 3 TOPOLOGY FILE 4 : WATER.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1SB8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-FEB-04. REMARK 100 THE DEPOSITION ID IS D_1000021576. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-NOV-02 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : 4.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23213 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 41.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.32800 REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PARTIALLY REFINED MODEL OF PDB ENTRY 1SB9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 600, PHOSPHATE-CITRATE BUFFER, PH REMARK 280 4.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 69.81900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 69.81900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 30.21900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 47.93850 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 30.21900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 47.93850 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 69.81900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 30.21900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 47.93850 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 69.81900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 30.21900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 47.93850 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HOMODIMER GENERATED FROM THE REMARK 300 MONOMER IN THE ASYMMETRIC UNIT BY THE OPERATION: X, -Y, -Z+1 REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 7000 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25180 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 139.63800 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 HIS A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 MET A -1 REMARK 465 GLY A 0 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 103 114.32 75.52 REMARK 500 ASN A 195 80.77 27.36 REMARK 500 ASP A 235 73.65 -106.63 REMARK 500 ALA A 264 -153.58 -164.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 342 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UD2 A 343 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1SB9 RELATED DB: PDB REMARK 900 UDP-N-ACETYLGLUCOSAMINE 4-EPIMERASE COMPLEXED WITH NAD AND UDP- REMARK 900 GLUCOSE DBREF 1SB8 A 1 341 GB 20560072 AAM27817 1 341 SEQADV 1SB8 MET A -10 GB 20560072 INITIATING METHIONINE SEQADV 1SB8 HIS A -9 GB 20560072 EXPRESSION TAG SEQADV 1SB8 HIS A -8 GB 20560072 EXPRESSION TAG SEQADV 1SB8 HIS A -7 GB 20560072 EXPRESSION TAG SEQADV 1SB8 HIS A -6 GB 20560072 EXPRESSION TAG SEQADV 1SB8 HIS A -5 GB 20560072 EXPRESSION TAG SEQADV 1SB8 HIS A -4 GB 20560072 EXPRESSION TAG SEQADV 1SB8 GLY A -3 GB 20560072 CLONING ARTIFACT SEQADV 1SB8 SER A -2 GB 20560072 CLONING ARTIFACT SEQADV 1SB8 MET A -1 GB 20560072 CLONING ARTIFACT SEQADV 1SB8 GLY A 0 GB 20560072 CLONING ARTIFACT SEQRES 1 A 352 MET HIS HIS HIS HIS HIS HIS GLY SER MET GLY MET MET SEQRES 2 A 352 SER ARG TYR GLU GLU LEU ARG LYS GLU LEU PRO ALA GLN SEQRES 3 A 352 PRO LYS VAL TRP LEU ILE THR GLY VAL ALA GLY PHE ILE SEQRES 4 A 352 GLY SER ASN LEU LEU GLU THR LEU LEU LYS LEU ASP GLN SEQRES 5 A 352 LYS VAL VAL GLY LEU ASP ASN PHE ALA THR GLY HIS GLN SEQRES 6 A 352 ARG ASN LEU ASP GLU VAL ARG SER LEU VAL SER GLU LYS SEQRES 7 A 352 GLN TRP SER ASN PHE LYS PHE ILE GLN GLY ASP ILE ARG SEQRES 8 A 352 ASN LEU ASP ASP CYS ASN ASN ALA CYS ALA GLY VAL ASP SEQRES 9 A 352 TYR VAL LEU HIS GLN ALA ALA LEU GLY SER VAL PRO ARG SEQRES 10 A 352 SER ILE ASN ASP PRO ILE THR SER ASN ALA THR ASN ILE SEQRES 11 A 352 ASP GLY PHE LEU ASN MET LEU ILE ALA ALA ARG ASP ALA SEQRES 12 A 352 LYS VAL GLN SER PHE THR TYR ALA ALA SER SER SER THR SEQRES 13 A 352 TYR GLY ASP HIS PRO GLY LEU PRO LYS VAL GLU ASP THR SEQRES 14 A 352 ILE GLY LYS PRO LEU SER PRO TYR ALA VAL THR LYS TYR SEQRES 15 A 352 VAL ASN GLU LEU TYR ALA ASP VAL PHE SER ARG CYS TYR SEQRES 16 A 352 GLY PHE SER THR ILE GLY LEU ARG TYR PHE ASN VAL PHE SEQRES 17 A 352 GLY ARG ARG GLN ASP PRO ASN GLY ALA TYR ALA ALA VAL SEQRES 18 A 352 ILE PRO LYS TRP THR SER SER MET ILE GLN GLY ASP ASP SEQRES 19 A 352 VAL TYR ILE ASN GLY ASP GLY GLU THR SER ARG ASP PHE SEQRES 20 A 352 CYS TYR ILE GLU ASN THR VAL GLN ALA ASN LEU LEU ALA SEQRES 21 A 352 ALA THR ALA GLY LEU ASP ALA ARG ASN GLN VAL TYR ASN SEQRES 22 A 352 ILE ALA VAL GLY GLY ARG THR SER LEU ASN GLN LEU PHE SEQRES 23 A 352 PHE ALA LEU ARG ASP GLY LEU ALA GLU ASN GLY VAL SER SEQRES 24 A 352 TYR HIS ARG GLU PRO VAL TYR ARG ASP PHE ARG GLU GLY SEQRES 25 A 352 ASP VAL ARG HIS SER LEU ALA ASP ILE SER LYS ALA ALA SEQRES 26 A 352 LYS LEU LEU GLY TYR ALA PRO LYS TYR ASP VAL SER ALA SEQRES 27 A 352 GLY VAL ALA LEU ALA MET PRO TRP TYR ILE MET PHE LEU SEQRES 28 A 352 LYS HET NAD A 342 44 HET UD2 A 343 39 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM UD2 URIDINE-DIPHOSPHATE-N-ACETYLGALACTOSAMINE HETSYN UD2 (2R,3R,4R,5R,6R)-3-(ACETYLAMINO)-4,5-DIHYDROXY-6- HETSYN 2 UD2 (HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-2-YL [(2R,3S,4R, HETSYN 3 UD2 5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-3,4- HETSYN 4 UD2 DIHYDROXYTETRAHYDROFURAN-2-YL]METHYL DIHYDROGEN HETSYN 5 UD2 DIPHOSPHATE FORMUL 2 NAD C21 H27 N7 O14 P2 FORMUL 3 UD2 C17 H27 N3 O17 P2 FORMUL 4 HOH *182(H2 O) HELIX 1 1 SER A 3 GLN A 15 1 13 HELIX 2 2 GLY A 26 LEU A 39 1 14 HELIX 3 3 HIS A 53 VAL A 64 1 12 HELIX 4 4 SER A 65 SER A 70 1 6 HELIX 5 5 ASN A 81 ALA A 90 1 10 HELIX 6 6 SER A 103 ASP A 110 1 8 HELIX 7 7 ASP A 110 ILE A 119 1 10 HELIX 8 8 ILE A 119 ALA A 132 1 14 HELIX 9 9 SER A 144 GLY A 147 5 4 HELIX 10 10 SER A 164 GLY A 185 1 22 HELIX 11 11 ALA A 209 GLY A 221 1 13 HELIX 12 12 ILE A 239 THR A 251 1 13 HELIX 13 13 ALA A 252 ALA A 252 5 1 HELIX 14 14 GLY A 253 ARG A 257 5 5 HELIX 15 15 LEU A 271 ASN A 285 1 15 HELIX 16 16 ILE A 310 LEU A 317 1 8 HELIX 17 17 ASP A 324 LEU A 340 1 17 SHEET 1 A 7 PHE A 72 GLN A 76 0 SHEET 2 A 7 LYS A 42 ASP A 47 1 N GLY A 45 O LYS A 73 SHEET 3 A 7 VAL A 18 THR A 22 1 N TRP A 19 O VAL A 44 SHEET 4 A 7 TYR A 94 HIS A 97 1 O LEU A 96 N LEU A 20 SHEET 5 A 7 SER A 136 SER A 142 1 O THR A 138 N HIS A 97 SHEET 6 A 7 ILE A 189 TYR A 193 1 O LEU A 191 N ALA A 141 SHEET 7 A 7 GLN A 259 ILE A 263 1 O ILE A 263 N ARG A 192 SHEET 1 B 2 VAL A 196 PHE A 197 0 SHEET 2 B 2 CYS A 237 TYR A 238 1 O CYS A 237 N PHE A 197 SHEET 1 C 2 TYR A 225 ASN A 227 0 SHEET 2 C 2 VAL A 294 ARG A 296 1 O ARG A 296 N ILE A 226 SHEET 1 D 2 SER A 233 ARG A 234 0 SHEET 2 D 2 THR A 269 SER A 270 -1 O THR A 269 N ARG A 234 CISPEP 1 LEU A 152 PRO A 153 0 -0.15 SITE 1 AC1 34 GLY A 23 ALA A 25 GLY A 26 PHE A 27 SITE 2 AC1 34 ILE A 28 ASP A 47 ASN A 48 PHE A 49 SITE 3 AC1 34 ALA A 50 THR A 51 GLY A 52 GLY A 77 SITE 4 AC1 34 ASP A 78 ILE A 79 GLN A 98 ALA A 99 SITE 5 AC1 34 ALA A 100 THR A 117 ALA A 140 ALA A 141 SITE 6 AC1 34 TYR A 166 LYS A 170 TYR A 193 ASN A 195 SITE 7 AC1 34 VAL A 196 UD2 A 343 HOH A 348 HOH A 349 SITE 8 AC1 34 HOH A 353 HOH A 360 HOH A 373 HOH A 405 SITE 9 AC1 34 HOH A 437 HOH A 481 SITE 1 AC2 28 SER A 103 SER A 142 SER A 143 SER A 144 SITE 2 AC2 28 TYR A 166 TYR A 193 ASN A 195 ALA A 209 SITE 3 AC2 28 VAL A 210 TRP A 214 TYR A 225 ILE A 226 SITE 4 AC2 28 ASN A 227 THR A 232 ARG A 234 LEU A 271 SITE 5 AC2 28 ARG A 299 ASP A 302 VAL A 303 SER A 306 SITE 6 AC2 28 NAD A 342 HOH A 356 HOH A 364 HOH A 375 SITE 7 AC2 28 HOH A 381 HOH A 393 HOH A 399 HOH A 402 CRYST1 60.438 95.877 139.638 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016546 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010430 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007161 0.00000